2018 annual financial data
Neuphoria Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -125.8%.
Operating income was -21,279,465 USD and net income was -18,427,652 USD.
Operating cash flow was -15,024,456 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 11,942,805 USD
- Operating income
- -21,279,465 USD
- Net income
- -18,427,652 USD
- Operating cash flow
- -15,024,456 USD